Mistletoe therapy aims to stop osteosarcoma relapse
NCT ID NCT05726383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a mistletoe extract (Iscador P) in 32 patients whose osteosarcoma has returned in the lungs and has been surgically removed. The goal is to see if the treatment can delay or prevent the cancer from coming back. Participants receive injections of the extract and are monitored with CT scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOGENIC SARCOMA RECURRENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
-
M.D. Anderson Children's Cancer Hospital
RECRUITINGHouston, Texas, 77030, United States